-
Canada approves BCL-2 inhibitor VENCLEXTA in combination with CD20 monoobinutuzumab for previously untreated patients with chronic lymphocytic leukemia
Time of Update: 2020-05-29
AbbVie announced that Health Canada has approved VENCLEXTA (venetoclax) in conjunction with anti-CD20 obinutuzumab for use in previously untreated adult patients with chronic lymphocytic leukemia (
-
Nat Gene: "Mutation" cells compete with each other to help prevent cancer
Time of Update: 2020-05-29
Introduction: Clones are cell communities formed by the division of a single stem cell through normal cells Mutations in human tissue, pieced together by clones, naturally occur throughout the life
-
ASCO 2020: Conference Summary Online
Time of Update: 2020-05-29
affected by medical needs, patient tissue, payment environment and other factors, cancer is still the main investment direction of the pharmaceutical industry Because tumor phenotypes are relativel
-
FDA approves first drug for RET gene mutation or fusion cancer -- Retevmo
Time of Update: 2020-05-29
U.S Food and Drug Administration approved Lilly's Retevinib for the treatment of tumors with mutations or fusions in three RET genes -- non-small cell lung cancer (NSCLC), thyroid myelin carcinoma
-
Lancet Haematol: Can the new target drug replace the transplantation of self-producing hematopoietic stem cells?
Time of Update: 2020-05-29
The emergence of highly active new drugs has led some to question the role of self-gene stem cell transplantation (HSCT) and subsequent consolidation therapy in newly diagnosed multiple myeloma The
-
FDA approves Ripretinib for treatment of advanced gastrointestinal mesotypes! Reding Pharma Holds China Interests
Time of Update: 2020-05-29
On May 15, Deciphera Pharmaceuticals announced that the FDA had approved the listing of its Qinlock (ripretinib) for the treatment of patients with advanced gastrointestinal interthelemic sylloma (
-
Cell Death Dis: The therapeutic effect of carbapenems on chronic ulcerative colitis
Time of Update: 2020-05-29
Ulcerative colitis (UC) is a difficult-to-treat chronic inflammatory bowel disease (IBD) characterized by severe diarrhea, abnormal weight loss, stool blood, abdominal pain and fatigue THE INFLAMMA
-
NEJM: Olapani Treats Metastatic Drug-resistant Prostate Cancer
Time of Update: 2020-05-29
Multiple cancers are associated with polysephonic (diphosphate adenosine-ribose) polymerase (PARP), and researchers recently looked at the effectiveness of Orapani's treatment for prostate cancer
-
FDA approves Dartumumab subcutaneous preparation for treatment of multiple myeloma
Time of Update: 2020-05-29
The FDA recently approved Johnson and Johnson's Dartumab subcutaneous preparation to treat multiple myeloma in adults The treatment will be sold under the name Darzalex Faspro Darzalex Faspro can b
-
Brit J Cancer: Prognosis of preoperative and postoperative tumor markers in patients with stomach cancer
Time of Update: 2020-05-29
In clinical practice, cancer embryo antigen (CEA) and CA19-9 are the most commonly measured markers before and after gastric cancer (GC) surgery However, it is not clear whether preoperative or pos
-
Radiology: Convolution-based neural network software can improve the detection rate of malignant tumors in chest
Time of Update: 2020-05-29
Background the additional benefits of detecting malignant lung tumor nodules in chest syllomas using deep convolutional neural network (DCNN) software are yet to be verified by multicenter studie
-
Cell Death Dis: The Role and Potential Mechanism of BECN1 in Colorectal Cancer Metastay
Time of Update: 2020-05-29
Cell autophagy is a life-promoting response involving the capture, degradation and recovery of intracellular proteins and organelles in lysosomes The enhancement of cell autophagy in cancer can pro
-
Brit J Heamatol: Incidence and prognosis of heparin-induced thrombocytin-induced thrombocytin in patients with solid malignancies
Time of Update: 2020-05-29
Heparin-induced thrombocytin (HIT) is an adverse reaction of the body to immunomediated reactions to heparin products, characterized by or not accompanied by thrombosis Recently, a study published
-
Mutations, detection, drugs and drug resistance to metgenees
Time of Update: 2020-05-29
Mutation forms of met gene the mutation of the MET gene and tumor occurrence or development there is a causal relationship, these mutation sites include V1110I, H1112Y / R, F1218I, D1246H / V, Y1
-
A case of malignant peripheral neurosyma in the liver
Time of Update: 2020-05-29
Patient female, 53 years old 1 week ago no obvious causes of right upper abdominal pain, when inhaling obvious, accompanied by fever and chills, the highest body temperature of 38.6 degrees C No na
-
Through the tumor cells
Time of Update: 2020-05-29
It's no stranger to the word, so how did this tumor cell pass throughit??? Please allow me to give you a detailed .. 01 cases have been A windy and suny afternoon, I am changxiang in the sea of m
-
J Cell Physiol: Study on immune-related genes and immune cell immersion in tumor microenvironments of diffuse low-gliomas
Time of Update: 2020-05-29
Tumor microenvironment is highly correlated with tumor occurrence, progression and prognosis The purpose of this study was to explore the expression and immuno-immersion patterns of immune-related
-
Nat Med: First evidence suggests genetic influences cancer metastasis
Time of Update: 2020-05-29
Recently, scientists at Rockefeller University in New York have conducted animal and human studies that have obtained evidence for the first time that a person's original genetic composition may affect the likelihood of cancer progression and metastasis The findings could change the way scientists think about cancer metastasis and help provide a basis for treatment decisions by better understanding the risks of patients The study was published in the journal Nature Medicine Background how do cancer cells generally metastasize?
-
Study on the mechanism of the new anti-glioma chemotherapy drug ACT001
Time of Update: 2020-05-29
Platinum drugs such as cisplatin are chemotherapy drugs for glioblastoma (GBM), often used in combination with tamoxamine, carmostine, etc., but their resistance and side effects limit clinical applic
-
Aging: New Immune-Related Gene Prognosis Biomarkers for Melanoma: Related to Tumor Microenvironment
Time of Update: 2020-05-29
Melanoma is a form of skin cancer that can spread to other organs and is the cause of death in most skin cancer patients Therefore, the identification of immunobiomarkers for the early diagnosis an
